Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexalin Technology (NXL) EBITDA (2022 - 2025)

Historic EBITDA for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.

  • Nexalin Technology's EBITDA rose 697.59% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year decrease of 5622.18%. This contributed to the annual value of -$7.6 million for FY2024, which is 6236.07% down from last year.
  • Per Nexalin Technology's latest filing, its EBITDA stood at -$2.3 million for Q3 2025, which was up 697.59% from -$1.6 million recorded in Q2 2025.
  • Nexalin Technology's EBITDA's 5-year high stood at -$135401.0 during Q3 2022, with a 5-year trough of -$2.8 million in Q4 2024.
  • Over the past 4 years, Nexalin Technology's median EBITDA value was -$1.0 million (recorded in 2024), while the average stood at -$1.3 million.
  • Per our database at Business Quant, Nexalin Technology's EBITDA crashed by 162042.89% in 2023 and then surged by 697.59% in 2025.
  • Over the past 4 years, Nexalin Technology's EBITDA (Quarter) stood at -$693364.0 in 2022, then fell by 12.77% to -$781874.0 in 2023, then crashed by 262.39% to -$2.8 million in 2024, then increased by 19.61% to -$2.3 million in 2025.
  • Its EBITDA was -$2.3 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$2.0 million in Q1 2025.